Answers are grounded in this paper and cite their sources.
The occurrence of increased amounts of por- phyrin in the urine in cases of liver disease was first duly emphasized by Archibald Garrod (1, 2).Garrod believed this to be hematoporphyrin, a confusion with coproporphyrin which was cor- rected by H. Fischer and Zerweck (3), and which undoubtedly depended upon the very close similarity of the absorption spectra of the two por- phyrins.When examined with the relatively crude spectroscopes available at the time of Garrod's study, these porphyrins were indistinguishable.The investigations of H. Fischer, however, made it clear that hematoporphyrin does not occur in the urine, if, indeed, it occurs as a natural product at all.Studies of urinary porphyrin excretion in liver disease, subsequent to that of Garrod, have been for the most part of rather fragmentary na- ture, consisting of one or not more than a few examples of any one affection.The pertinent literature has been reviewed within recent years (4, 5) and need not be considered here.Attention may be drawn, however, to the papers of Nesbitt and Snell (6, 7) and Localio and co-workers (8), in which considerable data were reported on the feces- urine ratio of coproporphyrin both in obstructive jaundice and liver disease.The papers of Watson (9, 10) and Dobriner (11 ) present limited data on I Aided by grants from the John and Mary R.
No takes yet. Share an insight, caveat, or question.
Watson et al. (1949) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: